Company: RGBP
Filing Date: 2025-05-28
Form Type: 10-Q
Source: 0001641172-25-012619
Chunk: 13

Company: Regen BioPharma Inc
Filing Date: 2025-05-28
Form: 10-Q
Item: Part I, Item 1
Chunk 13
---
 $200,000                           200,584  
  Lender 5                    $400,000                           401,168  
  Lender 6                    $252,525                                 -  
  Lender 7                     $38,617                                 -  
  Total                     $1,691,143      $                  1,404,090  
  Derivative liability      $1,691,143      $                  1,404,090  

9. STOCKHOLDERS’ EQUITY

The
stockholders’ equity section of the Company contains the following classes of capital stock as of March 31, 2025:

Common
stock, $ 0.0001 5,800,000,000 21,554,704

With
respect to each matter submitted to a vote of stockholders of the Corporation, each holder of Common Stock shall be entitled to cast
that number of votes which is equivalent to the number of shares of Common Stock owned by such holder times one (1).

On
any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the holders of the Common Stock shall receive,
out of assets legally available for distribution to the Company’s stockholders, a ratable share in the assets of the Corporation.

Preferred
Stock, $ 0.0001 800,000,000 600,000 34 739,000,000 10,123,771 60,000,000 29,338 20,000 15,007

The
abovementioned shares authorized pursuant to the Company’s certificate of incorporation may be issued from time to time without
prior approval of the shareholders. The Board of Directors of the Company shall have the full authority permitted by law to establish
one or more series and the number of shares constituting each such series and to fix by resolution full or limited, multiple or fractional,
or no voting rights, and such designations, preferences, qualifications, restrictions, options, conversion rights and other special or
relative rights of any series of the Stock that may be desired.

Series
AA Preferred Stock

On
September 15, 2014 the Company filed a CERTIFICATE OF DESIGNATION (“ Certificate of Designations”) with the Nevada Secretary
of State setting forth the preferences rights and limitations of a newly authorized series of preferred stock designated and known as
“ Series AA Preferred Stock” (hereinafter referred to as “ Series AA Preferred Stock”).

The
Board of Directors of the Company have authorized